StockSelector.com
  Research, Select, & Monitor Wednesday, December 12, 2018 8:34:38 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$147.93$1.36.93%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 1433 out of 7529 stocks based on 16 positive rankings and 6 negative rankings.

Positive Rankings
Positive Guidance
Within the past 90 days Ligand Pharmaceuticals has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Highest Net Margin
Ligand Pharmaceuticals rank is 99
Beat Whisper
According to EarningsWhispers.com, Ligand Pharmaceuticals beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Target Prices
The average analysts' target price is $280.00 for Ligand Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Ligand Pharmaceuticals is ranked 117.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 339
Estimated EPS Growth
Ligand Pharmaceuticals rank is 350
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Top Industry Values
Ligand Pharmaceuticals rank is 580
Top Intrinsic Values
Ligand Pharmaceuticals rank is 600
PEGValue
Ligand Pharmaceuticals has a PEG Value of $158.89. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 8.41% in the next year. Among companies with a PEG Value above the current stock price, Ligand Pharmaceuticals is ranked 835.
SSValue
The StockSelector Value for Ligand Pharmaceuticals is $205.83. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ligand Pharmaceuticals is ranked 1113.
Highest Cash Growth
Ligand Pharmaceuticals rank is 1184
Oversold Stochastics
Ligand Pharmaceuticals rank is 1321
Debt-to-Equity
Ligand Pharmaceuticals rank is 1497
Highest ROA
Ligand Pharmaceuticals rank is 2450
Highest ROE
Ligand Pharmaceuticals rank is 2978
Negative Rankings
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 9.72 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 95.
Price-to-Sales
Ligand Pharmaceuticals rank is 350
Price-to-Book
Ligand Pharmaceuticals rank is 543
High Put/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 1.33 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 556.
90 Day Loss
Ligand Pharmaceuticals rank is 843
10 Day Loss
Ligand Pharmaceuticals rank is 1718







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.